Fuel Knowledge, Empower Health

Explore the latest insights and studies on nutrition, uncovering how food impacts wellness and performance. Evidence-based research to guide smarter, healthier choices.


The science behind our model

Evidence that low‑carb, whole‑food care improves health—and operations

Open‑access findings you can read and share. Designed for clinicians, investors, and families.

Evidence‑Based Strategies

Effects of Ketogenic Diet on Health Outcomes: An Umbrella Review

BMC Medicine (2023) — Open Access

Synthesis of 100+ studies: clinically supervised low‑carb/ketogenic approaches reduce body weight, HbA1c, and triglycerides. Emphasizes individualized planning and monitoring.                                                                                           

Read Study

Nutrition Grounded in Research

Ketogenic Diet & Multiple Health Outcomes: Review of Meta‑Analyses

Frontiers in Nutrition (2023) — Open Access

Benefits for type 2 diabetes, obesity, and neurological conditions; notes LDL may rise in some individuals—supporting routine lipid monitoring and fat‑quality guidance.                                                                                                                        

Read Study

Lasting Impact

Low‑Carb Patterns & All‑Cause Mortality (NHANES 2001–2018)

Nature Scientific Reports (2024) — Open Access

U.S. population analysis suggests low‑carb adherence is associated with lower overall mortality risk. Observational—supports potential long‑term benefit while acknowledging limitations.

Read Study

Collaborative Partnership

Malnutrition Quality Improvement Initiative (MQii) Toolkit

Academy of Nutrition & Dietetics — Open Toolkit

Team‑based workflows for screening, assessment, intervention, and discharge planning. Ready‑to‑use measures to embed nutrition care across hospitals, rehab, and long‑term care.

Explore Toolkit

Clinical Personalization

Ketogenic Diet Reshapes the Human Metabolic Fingerprint

Clinical Nutrition (2023) — Open Access

Prospective human data show broad metabolomic shifts under ketogenic nutrition—supporting biomarker‑guided personalization and adherence monitoring in real‑world settings.                                                              

Read Article

Why Low‑Carb & Ketogenic Nutrition Saves Healthcare Dollars?

Clinically validated, cost‑effective, and scalable — evidence shows low‑carb nutrition not only improves metabolic health but reduces long‑term healthcare spending through fewer medications, hospitalizations, and complications.

Reduced Medication Costs

In a 2‑year diabetes study, ketogenic participants cut outpatient spending by $286 per patient per month and prescription costs by $105 per month, mainly from deprescribing insulin and oral diabetes drugs.

Source: Virta Health 2‑Year Outcomes Study (PMC10987085)                                                                   

Lower Chronic‑Disease Spend

Carbohydrate restriction improves insulin sensitivity, triglycerides, and blood sugar — reducing long‑term costs tied to diabetes, heart disease, and metabolic syndrome management.

Umbrella Review: BMC Medicine (2023)                                                                                                                                  

Sustainable Weight & Energy Gains

Participants in structured low‑carb programs average 15% body‑weight loss at 1 year with fewer hunger rebounds — preventing costly relapses and hospital visits related to obesity‑driven complications.

Frontiers in Nutrition, 2025 (TOWARD Study)                                                                                                            

Improved Cognition & Mood

Stable blood sugar and ketone metabolism improve energy, cognition, and focus — helping seniors maintain independence and reducing assisted‑care intensity needs over time.

Cambridge University Review (2024)                                                     

Return on Health Investment

Average $1,700 annual savings per patient in medication deprescriptions, versus $13,000/year for GLP‑1 drugs — demonstrating that lifestyle‑based care delivers lasting ROI.

Frontiers in Nutrition (2025)